Wolf KI, Jha A, van Berkel A, Wild D, Janssen I, Millo CM, Janssen M, Gonzales M, Timmers HJ, Pacak K
Metastatic paraganglioma treatment options are limited. Peptide receptor radionuclide therapy (PRRT) has been introduced as a novel management option for metastatic neuroendocrine tumors demonstrating safety, efficacy, and increased quality of...